Videos de Experimentos Relacionados
La bioinequivalencia genérica es la bioinequivalencia genérica.
Lancet (London, England)
|August 29, 1987
Resumen
No abstract available in PubMed .
Videos de Conceptos Relacionados
También podría leer
Artículos Relacionados
Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.
Ordenar por
Same author
Tamoxifen metabolism predicts drug concentrations and outcome in premenopausal patients with early breast cancer.
The pharmacogenomics journal·2014
Same author
CYP2D6 genotype and adjuvant tamoxifen: meta-analysis of heterogeneous study populations.
Clinical pharmacology and therapeutics·2013
Same author
[Pharmacogenetics: current state after 30 years of research].
Deutsche medizinische Wochenschrift (1946)·2013
Same author
Activity levels of tamoxifen metabolites at the estrogen receptor and the impact of genetic polymorphisms of phase I and II enzymes on their concentration levels in plasma.
Clinical pharmacology and therapeutics·2011
Same author
X-ray-assisted formation of gold nanoparticles in soda lime silicate glass: suppressed Ostwald ripening.
Physical review letters·2011
Same author
The impact of thyroid disease on the regulation, expression, and function of ABCB1 (MDR1/P glycoprotein) and consequences for the disposition of digoxin.
Clinical pharmacology and therapeutics·2010
Same journal
Assisted dying and the silencing of medicine's next generation.
Lancet (London, England)·2026
Same journal
Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.
Lancet (London, England)·2026
Same journal
Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.
Lancet (London, England)·2026
Same journal
[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.
Lancet (London, England)·2026
Same journal
Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.
Lancet (London, England)·2026